AzTrials
AzTrials

SalivaNCT04670341

The Effect of Chewing the Tapioca Pearls in Bubble Tea Drinks

A study testing chewing tapioca pearls in bubble tea drinks and drink tea without chewing tapioca pearls in people with Saliva, run by Gadjah Mada University at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Bubble tea drinks contain tea and tapioca pearls. Chewing tapioca pearls in bubble tea drinks may increase salivary components. Because of its proteins, inorganic components, and enzymes, saliva plays an important role in the body's defense against bacteria and viruses. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Saliva
What is being tested?
chewing tapioca pearls in bubble tea drinks and drink tea without chewing tapioca pearls
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteIndonesia
Study dates
17 Sep 2020to 17 Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • good Oral Hygiene Index-Simplified (OHI-S) score

Who cannot join

  • taking medication
  • a history of dry mouth
  • smoking
  • systemic disease

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Faculty of Dentistry, Universitas Gadjah Mada

    Yogyakarta, 55281

Other trials in Indonesia

About this study

Official title: Quality Improvement of Saliva by Chewing Tapioca Pearls in Bubble Tea Drinks

Bubble tea drinks contain tea and tapioca pearls. Chewing tapioca pearls in bubble tea drinks may increase salivary components. Because of its proteins, inorganic components, and enzymes, saliva plays an important role in the body's defense against bacteria and viruses. This study aims to analyze the effect of chewing the tapioca pearls in bubble tea drinks on salivary C-reactive protein (CRP) and calcium (Ca) levels.

Read the detailed description

Sixty saliva samples were collected from 15 subjects. The inclusion criterion was 18-25 years of age. The exclusion criteria were receiving medication, using dentures, a history of dry mouth, smoking and systemic disease. In the first week of the experiment, subjects drank bubble tea as the intervention group. In the second week, the same subjects drank tea without pearls as the control group. Each subject drank the bubble tea for 5 minutes per day over 3 days. Saliva samples were collected on the first day before bubble tea consumption (pretest) and on the third day after tea consumption (posttest). Saliva collection was performed in the morning (09:00 a.m.-12:00 p.m.) for 1 minute. Salivary CRP levels were measured using an ELISA kit, and Ca levels were determined using a test kit.

Conditions
Saliva
Being tested
chewing tapioca pearls in bubble tea drinks, drink tea without chewing tapioca pearls
Keywords
bubble tea, salivary C-reactive protein, salivary calcium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • chewing tapioca pearls in bubble tea drinksOther

    Saliva was collected on the first day before bubble tea consumption (pretest) and on the third day after bubble tea consumption (posttest); collection was conducted in the morning (09:00 a.m.-12.00 p.m.).

  • drink tea without chewing tapioca pearlsOther

    Saliva was collected on the first day before drink tea without tapioca pearl (pretest) and on the third day after tea consumption (posttest); collection was conducted in the morning (09:00 a.m.-12.00 p.m.).

Study groups in NCT04670341
Study groupRoleWhat they receive
chewing tapioca pearls in the bubble tea drinksExperimentalIn the first week, the subjects drink as much as 100 ml of bubble tea over a span of 5 minutes once a day for 3 days
Receives: Other: chewing tapioca pearls in bubble tea drinks
drink tea without chewing tapioca pearlsPlacebo comparatorIn the second week, the subjects drink tea without tapioca pearls as much as 100 ml for 5 minutes per day for 3 days.
Receives: Other: drink tea without chewing tapioca pearls

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Salivary C-reactive protein (CRP) level

    Salivary CRP level was measured on the first day before chewing tapioca peals in the bubble tea drinks and drink tea. Salivary CRP level was measured on the third day after drink bubble tea and tea without tapioca pearls

    Measured: 3 days

Secondary outcomes (1)
  1. Calcium (Ca) level

    Ca level was measured on the first day before chewing tapioca peals in the bubble tea drinks and drink tea. Ca level was measured on the third day after drink bubble tea and tea without tapioca pearls

    Measured: 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2020
  2. Study start17 Sep 2020
  3. Primary completion17 Oct 2020
  4. Study completion17 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Crossover
Model description
In the first week of the experiment, subject chewing tapioca pearl inthe bubble tea. In the second week, the same subjects drink tea without chewing tapioca pearl
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04670341
Sponsor's protocol ID
FKGUGM1
Status last verified
Dec 2020
First submitted
9 Dec 2020
Last updated
17 Dec 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Handajani J, Kusumajati D, Fathiyah H, Susilowati H, Tandelilin RTC. Quality improvement of saliva by chewing tapioca pearls in bubble tea drinks: a randomized experimental trial: (Study on salivary C-reactive protein (CRP) and calcium (Ca) levels). F1000Res. 2021 Feb 1;10:56. doi: 10.12688/f1000research.28028.2. eCollection 2021.

    PubMed 35387272

Questions about this trial

What is this clinical trial studying?

A study testing chewing tapioca pearls in bubble tea drinks and drink tea without chewing tapioca pearls in people with Saliva, run by Gadjah Mada University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Salivary C-reactive protein (CRP) level (time frame: 3 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04670341, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in